BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Jiang YK, Li W, Qiu YY, Yue M. Advances in targeted therapy for human epidermal growth factor receptor 2 positive in advanced gastric cancer. World J Gastrointest Oncol 2024; 16(6): 2318-2334 [PMID: 38994153 DOI: 10.4251/wjgo.v16.i6.2318]
URL: https://www.wjgnet.com/2218-6190/full/v16/i6/2318.htm
Number Citing Articles
1
Jie Zhang, Chen Zhang, Ruichen Zang, Weiwu Chen, Yining Guo, Haofei Jiang, Jing Le, Kunyu Wang, Haobo Fan, Xudong Wang, Sisi Mo, Peng Gao, Wenhao Guo, Xinrong Jiang, Fengbin Gao, Junming Jiang, Juyan Zheng, Yuxing Chen, Yicheng Chen, Yanlan Yu, Guoqing Ding. Targeting MAN1B1 potently enhances bladder cancer antitumor immunity via deglycosylation of CD47Cancer Communications 2025;  doi: 10.1002/cac2.70040
2
Yao Zhou, Jie Gong, Xianguang Deng, Lele Shen, Anqi Ge, Hongqiao Fan, Jie Ling, Shiting Wu, Lifang Liu. A comprehensive exploration of adverse reactions to lapatinib: a disproportionate analysis based on the FAERS databaseExpert Opinion on Drug Safety 2025; : 1 doi: 10.1080/14740338.2025.2471515
3
Xiaozhi Xi, Shasha Guo, Yuchao Gu, Xuekai Wang, Qiang Wang. Challenges and opportunities in single-domain antibody-based tumor immunotherapyBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2025; 1880(2): 189284 doi: 10.1016/j.bbcan.2025.189284